Lifeward Ltd (LFWD) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Lifeward ltd   (NASDAQ: LFWD)

Lifeward ltd

Officers & Directors


Jeff Dykan
Chairman of the Board

Dr. John William Poduska
Director

Almog Adar
Vice President of Finance

Larry Jasinski
Director and Chief Executive Officer

Hadar Levy
Director

Randel Richner
Director

Mike Lawless
Chief Financial Officer

Joseph Turk
Director ,

Lifeward ltd currently has 81 employees.

  News about Lifeward ltd Key Personnel

Lifeward Ltd. Forecasts Strong 2025 Amid Impressive Growth and Strategic Capital Expansion,

Lifeward Ltd. (Nasdaq: LFWD), a key player in the healthcare sector focused on rehabilitation and recovery solutions, recently issued a year-end open letter to shareholders detailing its operational and commercial priorities for 2025. The letter provides insights into the company s recent performance, financial health, and strategic direction, signaling a robust outlook for the upcoming year. Optimistic Financial PositionIn the face of challenges within the healthcare sector, Lifeward is optimistic about its financial stability. Recent financing initiatives have bolstered the company’s capital base, allowing it to confidently state that it possesses sufficient cash flow to pursue its strategic goals. Signi...

nnLifeward Appoints Dr. Keith E. Tansey and Launches AlterG NEO to Transform Spinal Injury Rehabilitationnn,


In a move that underscores its commitment to pioneering advancements in spinal injury treatment and rehabilitation technology, Lifeward has made two significant announcements set to shape the landscape of healthcare. The appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research and the introduction of the AlterG NEO device are indicative of Lifeward s dedication to bridging cutting-edge research with transformative rehabilitation solutions.


A Leader in Spinal Injury Research
Dr. Keith E. Tansey, a distinguished past president of the American Spinal Injury Association, joins Lifeward with over three decades of extensive experience in the fields of spinal cord injur...

Exoskeleton Evolution: Lifeward Takes the Lead Amidst Medicare Collaborations and Competitor Setbacks

An Exoskeleton Revolution: Lifeward CEO Addressing Medicare Payment Rate and Collaboration Challenges with CMS
In a recent open letter to shareholders, the CEO of Lifeward, a leading exoskeleton manufacturer, discussed the progress made towards finalizing the Medicare payment rate for their latest generation of ReWalk Exoskeleton. The letter shed light on the challenges faced by the company in collaborating with the Centers for Medicare and Medicaid Services (CMS) to determine the payment rate, with a focus on commercial transaction values.
The letter comes at a crucial time for Lifeward, as their competitor, Rewalk Robotics Ltd, reported a cumulative net loss of $-16 million in the 12 months leading...






LFWD Management Effectiveness LFWD Revenue per Employee LFWD Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.